Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA OKs Exactech's pre-formed antibiotic hip spacer:

This article was originally published in Clinica

Executive Summary

Exactech has gained US clearance to sell what it claims is the first pre-formed, antibiotic-containing cement hip spacer in the US. Used in two-stage revision hip surgery, the InterSpace hip spacer allows for consistent and uniform release of antibiotic into the local infected area. It also offers patients the opportunity for improved function after the first stage treatment and better rehabilitation after the definitive second-stage operation, said the Gainesville, Florida firm. "This new device eliminates costly additional operating time and replaces the inconsistent quality of the intra-operatively hand-fashioned devices currently being used," said Exactech's CEO, Bill Petty.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057198

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel